stockrow
Friday 6 November 2026
Export HNGE’s income statement to Excel — free account
Hinge Health Inc.
HNGE Healthcare Health Information Services
Hinge Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $587.9 million, up 50.6% from fiscal 2024.
- Revenue
- +53.0%
- EPS
- +104.2%
- Free cash flow
- +441.1%
Quarter to June 2026, against a year earlier
114.97
1.01
−0.87%
Follow HNGE
Alert me
Hinge Health Inc. (HNGE) EPS (diluted)
Hinge Health Inc.'s EPS (diluted) for fiscal 2025 was −$7.77, compared with −$0.88 in fiscal 2024. Over the twelve months to 30 June 2026 it was $1.28. Hinge Health Inc. ranks 5th of 42 Health Information Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | −$7.77 | — |
| FY2024 | −$0.88 | — |
| FY2023 | −$8.31 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $0.52 | 26.83% |
| Mar 2026 | $0.41 | 10.81% |
| Dec 2025 | $0.37 | — |
| Sep 2025 | −$0.02 | — |
| 4 more quarters | Free account |
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| HQY HealthEquity, Inc. compare | $2.77 |
| BTSG BrightSpring Health Services, Inc. compare | $1.85 |
| HNGE Hinge Health Inc. | $1.28 |
| DOCS Doximity, Inc. compare | $0.72 |
| WAY Waystar Holding Corp. compare | $0.69 |
| PRVA Privia Health Group, Inc. compare | $0.27 |
| SDGR Schrodinger, Inc. compare | −$0.79 |
| TEM Tempus AI, Inc. compare | −$1.06 |
| HTFL Heartflow, Inc. compare | −$1.83 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on HNGE
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement